Skip to content
10-Q

Quarterly Report

Keros Therapeutics, Inc. KROS

0001664710-25-000070

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 40.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 40.61M sh
Shares Diluted Q2 2025 · Jun 30, 2025 41.15M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.1M sh
Shares Diluted Q2 2025 · Jun 30, 2024 35.89M sh
Capex Q2 2025 · Jun 30, 2025 $1.29M
Capex Q2 2025 · Jun 30, 2024 $1.26M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $131.55M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$84.36M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $690.22M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $559.93M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $405.86M
Stockholders Equity Q2 2025 · Jun 30, 2025 $706.73M
Stockholders Equity Q2 2025 · Mar 31, 2025 $728.87M
Stockholders Equity Q2 2025 · Dec 31, 2024 $571.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $420.92M
Stockholders Equity Q2 2025 · Mar 31, 2024 $453.95M
Stockholders Equity Q2 2025 · Dec 31, 2023 $332.21M
Current Liabilities Q2 2025 · Jun 30, 2025 $34.71M
Current Liabilities Q2 2025 · Dec 31, 2024 $27.45M
Total Liabilities Q2 2025 · Jun 30, 2025 $50.43M
Total Liabilities Q2 2025 · Dec 31, 2024 $44.33M
Current Assets Q2 2025 · Jun 30, 2025 $732.81M
Current Assets Q2 2025 · Dec 31, 2024 $588.89M
Total Assets Q2 2025 · Jun 30, 2025 $757.17M
Total Assets Q2 2025 · Dec 31, 2024 $615.89M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.76
Eps Diluted Q2 2025 · Jun 30, 2025 $2.86
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.25
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.46
Eps Basic Q2 2025 · Jun 30, 2025 −$0.76
Eps Basic Q2 2025 · Jun 30, 2025 $2.90
Eps Basic Q2 2025 · Jun 30, 2024 −$1.25
Eps Basic Q2 2025 · Jun 30, 2024 −$2.46
Sga Expense Q2 2025 · Jun 30, 2025 $14.48M
Sga Expense Q2 2025 · Jun 30, 2025 $24.98M
Sga Expense Q2 2025 · Jun 30, 2024 $9.96M
Sga Expense Q2 2025 · Jun 30, 2024 $20.27M
Rd Expense Q2 2025 · Jun 30, 2025 $43.5M
Rd Expense Q2 2025 · Jun 30, 2025 $92.21M
Rd Expense Q2 2025 · Jun 30, 2024 $40.52M
Rd Expense Q2 2025 · Jun 30, 2024 $78.77M
Net Income Q2 2025 · Jun 30, 2025 −$30.7M
Net Income Q2 2025 · Jun 30, 2025 $117.76M
Net Income Q2 2025 · Mar 31, 2025 $148.45M
Net Income Q2 2025 · Jun 30, 2024 −$45.26M
Net Income Q2 2025 · Jun 30, 2024 −$88.37M
Net Income Q2 2025 · Mar 31, 2024 −$43.11M
Operating Income Q2 2025 · Jun 30, 2025 −$39.82M
Operating Income Q2 2025 · Jun 30, 2025 $112.22M
Operating Income Q2 2025 · Jun 30, 2024 −$50.44M
Operating Income Q2 2025 · Jun 30, 2024 −$98.92M
Revenue Q2 2025 · Jun 30, 2025 $18.17M
Revenue Q2 2025 · Jun 30, 2025 $229.41M
Revenue Q2 2025 · Jun 30, 2024 $37K
Revenue Q2 2025 · Jun 30, 2024 $120K